Perrigo Revenue 2006-2020 | PRGO

Perrigo annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Perrigo revenue for the quarter ending June 30, 2020 was $1.219B, a 6.1% increase year-over-year.
  • Perrigo revenue for the twelve months ending June 30, 2020 was $5.074B, a 9.08% increase year-over-year.
  • Perrigo annual revenue for 2019 was $4.837B, a 2.23% increase from 2018.
  • Perrigo annual revenue for 2018 was $4.732B, a 4.34% decline from 2017.
  • Perrigo annual revenue for 2017 was $4.946B, a 6.33% decline from 2016.
Perrigo Annual Revenue
(Millions of US $)
2019 $4,837
2018 $4,732
2017 $4,946
2016 $5,281
2015 $2,632
2015 $4,227
2014 $3,914
2013 $3,540
2012 $3,173
2011 $2,755
2010 $2,268
2009 $2,006
2008 $1,730
2007 $1,368
2006 $1,367
2005 $1,024
Perrigo Quarterly Revenue
(Millions of US $)
2020-06-30 $1,219
2020-03-31 $1,341
2019-12-31 $1,323
2019-09-30 $1,191
2019-06-30 $1,149
2019-03-31 $1,175
2018-12-31 $1,195
2018-09-30 $1,133
2018-06-30 $1,186
2018-03-31 $1,217
2017-12-31 $1,283
2017-09-30 $1,231
2017-06-30 $1,238
2017-03-31 $1,194
2016-12-31 $1,331
2016-09-30 $1,262
2016-06-30 $1,341
2016-03-31 $1,347
2015-12-31 $-1,023
2015-09-30 $1,273
2015-06-30
2015-03-31 $967
2014-12-31 $1,072
2014-09-30 $952
2014-06-30
2014-03-31 $1,004
2013-12-31 $979
2013-09-30 $933
2013-06-30
2013-03-31 $920
2012-12-31 $883
2012-09-30 $770
2012-06-30
2012-03-31 $778
2011-12-31 $838
2011-09-30 $725
2011-06-30
2011-03-31 $692
2010-12-31 $718
2010-09-30 $641
2010-06-30
2010-03-31 $538
2009-12-31 $582
2009-09-30 $528
2009-06-30
2009-03-31 $506
2008-12-31 $537
2008-09-30 $456
2008-06-30
2008-03-31 $481
2007-12-31 $435
2007-09-30 $383
2007-06-30
2007-03-31 $362
2006-12-31 $371
2006-09-30 $340
2006-06-30
2006-03-31 $332
2005-12-31
2005-09-30 $320
2005-06-30
2005-03-31 $220
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.183B $4.837B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.001B 33.59
Medtronic (MDT) Ireland $135.860B 22.07
Stryker (SYK) United States $71.577B 27.76
Boston Scientific (BSX) United States $56.869B 32.85
Lonza Group Ag (LZAGY) Switzerland $46.267B 0.00
Baxter (BAX) United States $42.847B 26.20
Terumo (TRUMY) Japan $30.297B 38.73
EssilorLuxottica Societe Anonyme (ESLOY) France $28.806B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.554B 23.70
ResMed (RMD) United States $25.680B 37.29
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.382B 0.00
Bio-Rad Laboratories (BIO) United States $15.129B 68.43
Insulet (PODD) United States $13.561B 573.78
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.461B 55.42
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $6.424B 0.00
Hill-Rom Holdings (HRC) United States $6.414B 15.92
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.422B 0.00
Haemonetics (HAE) United States $4.266B 28.43
Neogen (NEOG) United States $4.124B 68.91
ICU Medical (ICUI) United States $3.954B 30.17
Envista Holdings (NVST) United States $3.841B 26.20
Abcam (ABCZY) $3.703B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.368B 0.00
National Vision Holdings (EYE) United States $2.893B 449.63
Agios Pharmaceuticals (AGIO) United States $2.839B 0.00
NuVasive (NUVA) United States $2.649B 36.91
TG Therapeutics (TGTX) United States $2.581B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.053B 187.31
AtriCure (ATRC) United States $1.816B 0.00
MacroGenics (MGNX) United States $1.504B 0.00
NanoString Technologies (NSTG) United States $1.495B 0.00
Aphria (APHA) Canada $1.338B 0.00
Aurora Cannabis (ACB) Canada $1.175B 0.00
Cerus (CERS) United States $1.172B 0.00
Cardiovascular Systems (CSII) United States $1.133B 0.00
Quanterix (QTRX) United States $1.066B 0.00
InMode (INMD) Israel $1.023B 25.80
Owens & Minor (OMI) United States $1.014B 22.71
OraSure Technologies (OSUR) United States $0.962B 0.00
Lantheus Holdings (LNTH) United States $0.904B 12.53
PetIQ (PETQ) United States $0.839B 24.24
Meridian Bioscience (VIVO) United States $0.784B 18.10
Phibro Animal Health (PAHC) United States $0.773B 15.42
Vapotherm (VAPO) United States $0.755B 0.00
Omeros (OMER) United States $0.719B 0.00
Surmodics (SRDX) United States $0.645B 70.73
BioLife Solutions (BLFS) United States $0.604B 314.50
Zynex (ZYXI) United States $0.588B 51.36
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Eagle Pharmaceuticals (EGRX) United States $0.585B 82.64
VAREX IMAGING (VREX) United States $0.502B 21.75
Viemed Healthcare (VMD) United States $0.415B 14.82
HEXO (HEXO) $0.376B 0.00
Cytosorbents (CTSO) United States $0.374B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.312B 0.00
Utah Medical Products (UTMD) $0.309B 26.53
InfuSystems Holdings (INFU) United States $0.274B 52.50
Organigram Holdings (OGI) Canada $0.244B 0.00
Exagen (XGN) United States $0.209B 0.00
Female Health (VERU) United States $0.186B 0.00
Chimerix (CMRX) United States $0.182B 0.00
Bovie Medical (APYX) United States $0.176B 0.00
Fonar (FONR) United States $0.168B 14.85
Surface Oncology (SURF) United States $0.166B 0.00
Wound Management Technologies (SMTI) United States $0.162B 0.00
Liberty Health Sciences (LHSIF) Canada $0.134B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Capricor Therapeutics (CAPR) United States $0.122B 0.00
Evolus (EOLS) United States $0.122B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
MTech Acquisition (KERN) United States $0.082B 0.00
Brainsway (BWAY) Israel $0.074B 0.00
United-Guardian (UG) United States $0.073B 16.36
Nephros (NEPH) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.051B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.034B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.025B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00